GoodRx advertising spend, FY2025
GoodRx (GDRX) reported $203M of advertising expense for the fiscal year ended Dec 31, 2025. That is 25.5% of revenue of $797M. Down 3.8% from FY2024.
Key facts
- Ad spend is 9% below its FY2020 level ($222M), while revenue grew 1.4x.
- The highest year on file is FY2021 at $297M; FY2025 is 31% below it.
- Largest increase +83.3% in FY2019; largest cut -23.7% in FY2022.
- Ad spend is 25.5% of revenue, down from 40.4% in FY2020.
- GoodRx spends more on advertising than 51% of the 458 US-listed companies tracked. Its ad-to-revenue ratio is 5.6x the median of 4.5%.
Ad spend by fiscal year
Ad spend as % of revenue
Ad spend in context, FY2025
Advertising was 1.7x research and development spending. Advertising exceeded operating income of $87.5M.
| Advertising | $203M | AdvertisingExpense |
|---|---|---|
| Selling and marketing | $332M | ad spend = 61.3% |
| Research and development | $121M | ad spend = 1.7x R&D |
| Operating income | $87.5M | ad spend = 2.3x |
| Net income | $30.4M |
Same fiscal year and filing as the ad spend. Selling and marketing and SG&A usually include advertising.
History
Download CSV| Fiscal year | Period end | Ad spend | YoY | Revenue | Ad / revenue | Tag | Filing |
|---|---|---|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | $203M | -3.8% | $797M | 25.5% | AdvertisingExpense | 10-K Feb 26, 2026 |
| FY2024 | Dec 31, 2024 | $211M | +6.3% | $792M | 26.7% | AdvertisingExpense | 10-K Feb 26, 2026 |
| FY2023 | Dec 31, 2023 | $199M | -12.2% | $750M | 26.5% | AdvertisingExpense | 10-K Feb 26, 2026 |
| FY2022 | Dec 31, 2022 | $226M | -23.7% | $767M | 29.5% | AdvertisingExpense | 10-K Feb 27, 2025 |
| FY2021 | Dec 31, 2021 | $297M | +33.4% | $745M | 39.8% | AdvertisingExpense | 10-K Feb 29, 2024 |
| FY2020 | Dec 31, 2020 | $222M | +35.9% | $551M | 40.4% | AdvertisingExpense | 10-K Mar 1, 2023 |
| FY2019 | Dec 31, 2019 | $164M | +83.3% | $388M | 42.2% | AdvertisingExpense | 10-K Mar 1, 2022 |
| FY2018 | Dec 31, 2018 | $89.3M | n/a | $250M | 35.8% | AdvertisingExpense | 10-K Mar 12, 2021 |
Ad spend, revenue and the ratio come from the linked filing. YoY compares each year with the fiscal year directly before it, under the same tag. A gap, a change of tag or a change of fiscal year end leaves it blank.
What the figure is
Advertising costs as disclosed in the annual report (XBRL tag AdvertisingExpense).
Compared with similar spenders
The 6 companies closest to GoodRx in latest-year ad spend.
| Rank | Company | Ad spend | Ad / revenue | YoY | Fiscal year |
|---|---|---|---|---|---|
| 221 | JOYY | $207M | 9.8% | -13.7% | FY2025 |
| 222 | Atlassian | $206M | 3.1% | +34.8% | FY2026 |
| 223 | Primo Brands | $206M | 3.1% | -5.9% | FY2025 |
| 224 | GoodRx | $203M | 25.5% | -3.8% | FY2025 |
| 225 | Vertex Pharmaceuticals | $203M | 1.7% | +136.6% | FY2025 |
| 226 | American Airlines Group | $200M | 0.4% | +39.9% | FY2025 |
| 227 | PPG Industries | $199M | 1.3% | -2.0% | FY2025 |
Full ranking of 458 companies · Biggest cuts #92 · Highest ad-to-revenue #30 · More on ads than R&D #71 · Ads above operating profit #69
Questions
How much does GoodRx spend on advertising?
GoodRx spent $203M on advertising in fiscal 2025, the year ended Dec 31, 2025, according to its 10-K filed Feb 26, 2026.
What percentage of revenue does GoodRx spend on advertising?
25.5% of revenue in fiscal 2025 ($203M against $797M). The median across the 458 companies tracked is 4.5%.
Is GoodRx spending more on advertising?
No. Ad spend fell 3.8% in fiscal 2025 from fiscal 2024.
How does GoodRx rank by advertising spend?
#224 of 458 US-listed companies with $50M or more in ad spend, ranked on each company's latest fiscal year.
Does GoodRx spend more on advertising than on R&D?
Yes. In fiscal 2025 it spent $203M on advertising and $121M on research and development.
What does GoodRx's advertising figure include?
Advertising costs as disclosed in the annual report (XBRL tag AdvertisingExpense).
Company and source
- Filing
- 10-K for FY2025, filed Feb 26, 2026
- Accession number
0001809519-26-000031- Company
- GoodRx Holdings, Inc., CIK 1809519, SIC 7374 (Services-Computer Processing & Data Preparation)
- Headquarters
- Santa Monica, CA
- Incorporated in
- DE
- Fiscal year ends
- December 31
- Listed on
- Nasdaq
- SEC filer status
- Accelerated filer
- Data
- SEC EDGAR XBRL company facts, retrieved Nov 18, 2026. Methodology.
- Cite
- GoodRx advertising spend, FY2018-FY2025. Aleksei Trudov, io.trudov.com, from SEC EDGAR XBRL company facts (latest: 10-K filed Feb 26, 2026), retrieved Nov 18, 2026. https://io.trudov.com/company/goodrx-holdings/advertising-spend/
- Download
- CSV, all years · CSV, all 458 companies